Lhasa Limited shared knowledge shared progress

In Silico Strategies to Assess Potentially Mutagenic Impurities Under ICH M7

pdf fileLepley L; Barber CG;

The ability to assess an impurity as either non-mutagenic or not present in the final API can offer significant efficiencies without compromising safety. In silico tools can provide a robust and cost-efficient solution, provided they are fit-for-purpose.

These are the slides and supporting workbook from the Lhasa Limited 2017 SOT vendor session in which an integrated solution to ICH M7 was reviewed. The case study was based on the synthetic scheme of Pimavanserin and included database/literature searching, in silico prediction using an expert rule-based and statistical-based system and consideration of the purging of intermediates.


Additional Documents

© 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.